ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,364,061 | -10.7% | 65,454 | +2.6% | 0.01% | -16.7% |
Q2 2023 | $1,527,268 | +10081.8% | 63,769 | +5967.5% | 0.01% | – |
Q2 2022 | $15,000 | -71.7% | 1,051 | -51.9% | 0.00% | – |
Q1 2022 | $53,000 | +8.2% | 2,184 | +4.9% | 0.00% | – |
Q4 2021 | $49,000 | +250.0% | 2,081 | +156.0% | 0.00% | – |
Q3 2021 | $14,000 | -74.1% | 813 | -62.9% | 0.00% | -100.0% |
Q2 2021 | $54,000 | -18.2% | 2,194 | -13.7% | 0.00% | 0.0% |
Q1 2021 | $66,000 | -30.5% | 2,543 | +42.5% | 0.00% | 0.0% |
Q4 2020 | $95,000 | +1087.5% | 1,785 | +1090.0% | 0.00% | – |
Q2 2020 | $8,000 | -11.1% | 150 | -57.1% | 0.00% | – |
Q2 2019 | $9,000 | 0.0% | 350 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | +50.0% | 350 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -60.0% | 350 | -51.2% | 0.00% | -100.0% |
Q3 2018 | $15,000 | 0.0% | 717 | -29.4% | 0.00% | 0.0% |
Q2 2018 | $15,000 | +66.7% | 1,015 | +125.6% | 0.00% | 0.0% |
Q1 2018 | $9,000 | -47.1% | 450 | -18.2% | 0.00% | 0.0% |
Q4 2017 | $17,000 | +70.0% | 550 | +57.1% | 0.00% | – |
Q3 2017 | $10,000 | – | 350 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |